{"nct_id":"NCT03713593","title":"Safety and Efficacy of Lenvatinib (E7080/MK-7902) in Combination With Pembrolizumab (MK-3475) Versus Lenvatinib as First-line Therapy in Participants With Advanced Hepatocellular Carcinoma (MK-7902-002/E7080-G000-311/LEAP-002)","status":"COMPLETED","status_verified_date":"2025-09","start_date":"2018-12-31","start_date_type":"ACTUAL","primary_completion_date":"2022-06-21","primary_completion_date_type":"ACTUAL","completion_date":"2024-09-24","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["MRK"]}